SPY332.80-2.77 -0.83%
DIA277.19-0.95 -0.34%
IXIC10,782.82-185.53 -1.69%

Acasti Pharma Q2 EPS $(0.34) Misses $(0.16) Estimate

Acasti Pharma (NASDAQ:ACST) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.16) by 112.5 percent. This is a 45.16 percent increase over losses of $(0.62) per share from

Benzinga · -

Acasti Pharma (NASDAQ:ACST) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.16) by 112.5 percent. This is a 45.16 percent increase over losses of $(0.62) per share from the same period last year.